WBR0367: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor=[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]] [mailto:gromero@wikidoc.org] |ExamType=USMLE Step 1 |MainCategory=Pharmacology |SubCategory=Cardio...")
 
m (refreshing WBR questions)
 
(14 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]] [mailto:gromero@wikidoc.org]
|QuestionAuthor=[[User:Serge korjian|Serge Korjian, M.D.]],[[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]] [mailto:gromero@wikidoc.org](Reviewed by Serge Korjian)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|SubCategory=Cardiology, General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|SubCategory=Cardiology, General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|SubCategory=Cardiology, General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|SubCategory=Cardiology, General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|SubCategory=Cardiology, General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|SubCategory=Cardiology, General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology, Dermatology, Gastrointestinal
|MainCategory=Pharmacology
|Prompt=A 25-year-old male patient comes to the clinic complaining of fatigue for over 4 weeks. The student states that this begun after a teacher assigned a project to each class member a group project to be discussed and presented at a conference in 6 months. He feels frightened about standing in front of a big crowd. Upon examination his vitals are: 124/80mmHg, HR: 120, RR: 21, Temp: 37C. The patient looks fidgety and has a rapid speech.   The patient is prescribed the drug of choice for this disorder. After 2 he months he decides to increase the dose and starts developing diarrhea,  wheezing and flushing. Which of the following could be used to treat this patient’s new symptoms?
|SubCategory=Cardiology, General Principles
|Explanation=This patient is presenting with Social phobia, also known as Social Anxiety Disorder. The treatment of choice of phobias short term include Beta blockers, such as Propranol and cognitive therapy. SSRIs which increase the are prescribed long term to treat to underlying anxiety. After a course of 2 months with treatment this patient is presenting with cutaneous flushing, diarrhea, and wheezing; typical characteristics of serotonin syndrome. This syndrome is due to an excess of serotonin. The treatment of choice for serotonin syndrome Cyproheptadine, a first generation antihistamine with anticholinergic, antiserotoninergic and local anesthetic properties.
|Prompt=A 25-year-old man is brought to the emergency department by ambulance for altered mental status. His mother contacted emergency medical services after finding him unconscious on his bedroom floor. She reports that her son is a very healthy person with no significant past medical history. He was only recently diagnosed with performance anxiety that was interfering with his daily functioning at his new job as a financial advisor. The mother also notes that her son has been very anxious for the past week because of an upcoming project presentation. On admission, the patient's blood pressure is 80/55 mm Hg, heart rate is 42/min, and temperature is 36.7 ᵒC (98 ᵒF). The patient is not responsive, but opens his eyes to painful stimuli. An ECG tracing is obtained and shown below. Which of the following medications is the most appropriate choice for the acute treatment of this patient?<br>
<br>
[[Image:WBR0367.jpg]]
<font color="MediumBlue"><font size="4">'''Educational Objective:''' </font></font> serotonin syndrome characterized by wheezing, flushing and diarrhea, can be treated with cyproheptadine, a first generation antihistamine which has anti-serotoninergic and anticholinergic properties.
|Explanation=The classical treatment for patients with performance anxiety is a non-selective beta-blocker, most commonly propranolol. A key consideration in this question, other than the consistent clinical presentation, is the possibility of self-medication with a higher dose of propranolol given an upcoming stressful event. Beta-blocker toxicity manifests as bradycardia, hypotension, atrioventricular block, arrhythmias, and seizures. Given the non-selective nature of propranolol, bronchospasm is also a possible complication particularly in patients with pre-existing bronchospastic pulmonary disease. The ECG tracing may vary, showing anything from simple sinus bradycardia to third degree block (seen in this patient's tracing). The initial management for patients with propranolol toxicity includes activated charcoal; however, given the altered mental status of the patient, charcoal should be withheld. Along with initial fluid administration, glucagon is the treatment of choice for patients with beta-blocker toxicity. Glucagon increases heart rate and myocardial contractility, and improves atrioventricular conduction. These properties are unaffected by the presence of beta-blockers suggesting that glucagon's mechanism of action may bypass the beta-adrenergic receptor site. This may also explain why atropine and isoproterenol are not very effective in reversing the bradycardia and hypotension of beta-blocker overdose.
|AnswerA=Cyproheptadine
|AnswerA=Cyproheptadine
|AnswerAExp=<font color="Green">'''Correct.'''</font> [[Cyproheptadine]] is used to treat the management of moderate to severe cases of serotonin syndrome. This excess of serotonin can be caused by SSRIs excess, MAO Inhibitors intoxication and carcinoid tumor.
|AnswerAExp=[[Cyproheptadine]] is used to treat moderate to severe cases of serotonin syndrome. The syndrome can be caused by SSRIs excess, or combination with MAO inhibitors, buspirone, meperidine, linezolid, and dextromethorphan.
|AnswerB=Glucagon
|AnswerB=Glucagon
|AnswerBExp=<font color="red">'''Incorrect.'''</font> [[Glucagon]] is used to reverse the intoxication of Betablockers.  
|AnswerBExp=[[Glucagon]] is the medication of choice to treat beta-blocker intoxication. It is hypothesized that glucagon works at a non-beta-adrenergic site to increase inotropy, and atrioventricular conduction.
|AnswerC=Flumazenile
|AnswerC=Flumazenil
|AnswerCExp=<font color="red">'''Incorrect.'''</font> [[Flumazenile]] reverses the effects of [[benzodiazepines]].
|AnswerCExp=[[Flumazenil]] is the antidote for [[benzodiazepine]] intoxication. It is both diagnostic and therapeutic.
|AnswerD=Naloxone
|AnswerD=Atropine
|AnswerDExp=<font color="red">'''Incorrect.'''</font> [[Naloxone]] is used to reverse acute intoxications with [[Opioids]].
|AnswerDExp=Although atropine can be used to increase heart rate in sinus bradycardia and certain forms of atrioventricular block, it is not very effective in the treatment of patients with beta-blocker toxicity. In addition, patients with third degree block do not benefit from atropine.
|AnswerE=Sodium bicarbonat
|AnswerE=Sodium bicarbonate
|AnswerEExp=<font color="red">'''Incorrect.'''</font> [[Sodium bicarbonate]] alkalinizes the urine allowing the elimination of acidic substances in the urine by inhibiting the reabsorption. It can be used in cases of Salicylates and TCAs intoxication.
|AnswerEExp=[[Sodium bicarbonate]] is the treatment of choice for TCA intoxication. Despite popular belief, the use of sodium bicarbonate in TCA toxicity is not aimed at alkalinizing the urine to increase its urinary excretion. It is used to provide a sodium load that corrects the QRS prolongation, and an alkaline blood pH to increase the protein bound fraction of the TCA.
|RightAnswer=A
|EducationalObjectives=Glucagon is the treatment of choice for patients with suspected or confirmed beta-blocker toxicity.
|References=Peterson CD, Leeder JS, Sterner S. Glucagon therapy for beta-blocker overdose. Drug Intell Clin Pharm. 1984;18(5):394-8.<br>
Kerr GW, Mcguffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236-41.
|RightAnswer=B
|WBRKeyword=propranolol, antidotes, beta-blocker, toxicity, glucagon,
|Approved=Yes
|Approved=Yes
}}
}}

Latest revision as of 00:19, 28 October 2020

 
Author [[PageAuthor::Serge Korjian, M.D.,Gonzalo A. Romero, M.D. [1](Reviewed by Serge Korjian)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Cardiology, SubCategory::General Principles
Prompt [[Prompt::A 25-year-old man is brought to the emergency department by ambulance for altered mental status. His mother contacted emergency medical services after finding him unconscious on his bedroom floor. She reports that her son is a very healthy person with no significant past medical history. He was only recently diagnosed with performance anxiety that was interfering with his daily functioning at his new job as a financial advisor. The mother also notes that her son has been very anxious for the past week because of an upcoming project presentation. On admission, the patient's blood pressure is 80/55 mm Hg, heart rate is 42/min, and temperature is 36.7 ᵒC (98 ᵒF). The patient is not responsive, but opens his eyes to painful stimuli. An ECG tracing is obtained and shown below. Which of the following medications is the most appropriate choice for the acute treatment of this patient?

]]

Answer A AnswerA::Cyproheptadine
Answer A Explanation [[AnswerAExp::Cyproheptadine is used to treat moderate to severe cases of serotonin syndrome. The syndrome can be caused by SSRIs excess, or combination with MAO inhibitors, buspirone, meperidine, linezolid, and dextromethorphan.]]
Answer B AnswerB::Glucagon
Answer B Explanation [[AnswerBExp::Glucagon is the medication of choice to treat beta-blocker intoxication. It is hypothesized that glucagon works at a non-beta-adrenergic site to increase inotropy, and atrioventricular conduction.]]
Answer C AnswerC::Flumazenil
Answer C Explanation [[AnswerCExp::Flumazenil is the antidote for benzodiazepine intoxication. It is both diagnostic and therapeutic.]]
Answer D AnswerD::Atropine
Answer D Explanation [[AnswerDExp::Although atropine can be used to increase heart rate in sinus bradycardia and certain forms of atrioventricular block, it is not very effective in the treatment of patients with beta-blocker toxicity. In addition, patients with third degree block do not benefit from atropine.]]
Answer E AnswerE::Sodium bicarbonate
Answer E Explanation [[AnswerEExp::Sodium bicarbonate is the treatment of choice for TCA intoxication. Despite popular belief, the use of sodium bicarbonate in TCA toxicity is not aimed at alkalinizing the urine to increase its urinary excretion. It is used to provide a sodium load that corrects the QRS prolongation, and an alkaline blood pH to increase the protein bound fraction of the TCA.]]
Right Answer RightAnswer::B
Explanation [[Explanation::The classical treatment for patients with performance anxiety is a non-selective beta-blocker, most commonly propranolol. A key consideration in this question, other than the consistent clinical presentation, is the possibility of self-medication with a higher dose of propranolol given an upcoming stressful event. Beta-blocker toxicity manifests as bradycardia, hypotension, atrioventricular block, arrhythmias, and seizures. Given the non-selective nature of propranolol, bronchospasm is also a possible complication particularly in patients with pre-existing bronchospastic pulmonary disease. The ECG tracing may vary, showing anything from simple sinus bradycardia to third degree block (seen in this patient's tracing). The initial management for patients with propranolol toxicity includes activated charcoal; however, given the altered mental status of the patient, charcoal should be withheld. Along with initial fluid administration, glucagon is the treatment of choice for patients with beta-blocker toxicity. Glucagon increases heart rate and myocardial contractility, and improves atrioventricular conduction. These properties are unaffected by the presence of beta-blockers suggesting that glucagon's mechanism of action may bypass the beta-adrenergic receptor site. This may also explain why atropine and isoproterenol are not very effective in reversing the bradycardia and hypotension of beta-blocker overdose.

Educational Objective: Glucagon is the treatment of choice for patients with suspected or confirmed beta-blocker toxicity.
References: Peterson CD, Leeder JS, Sterner S. Glucagon therapy for beta-blocker overdose. Drug Intell Clin Pharm. 1984;18(5):394-8.
Kerr GW, Mcguffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236-41.]]

Approved Approved::Yes
Keyword WBRKeyword::propranolol, WBRKeyword::antidotes, WBRKeyword::beta-blocker, WBRKeyword::toxicity, WBRKeyword::glucagon
Linked Question Linked::
Order in Linked Questions LinkedOrder::